Skip to content
Unrated Drug recall · FDA · Published June 4, 2013

VersaPharm Ethambutol Tablets Recalled for Discoloration

VersaPharm recalls 118 bottles of Ethambutol HCl 400 mg tablets due to surface ink defects. Check your lot number and consult a pharmacist.

🇺🇸 FDA recall #D-839-2013DrugVersaPharm ›
Take action

Contact the company

Recalling firmWest-Ward Pharmaceutical Corp.465 Industrial Way W · Eatontown, NJ 07724-2209
✎ GovInfoNow plain-language explainer

What happened, in plain English

VersaPharm Incorporated is recalling one lot of Ethambutol Hydrochloride Tablets, USP 400 mg because the tablets have a surface defect involving discoloration or an out-of-specification result for description testing. The affected product was distributed in Georgia. No remedy has been stated in this record. Read more at govinfonow.com/recall/47466-west-ward-pharmaceutical-corp-recalls-versapharm-incorporated-ethambutol-hydrochloride-tablets.

Source Summary by GovInfoNow · govinfonow.com/recall/47466-west-ward-pharmaceutical-corp-recalls-versapharm-incorporated-ethambutol-hydrochloride-tablets · Updated October 13, 2026 · FDA enforcement record: FDA #D-839-2013

Cite this page

“VersaPharm Ethambutol Tablets Recalled for Discoloration.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47466-west-ward-pharmaceutical-corp-recalls-versapharm-incorporated-ethambutol-hydrochloride-tablets. Based on FDA recall #D-839-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-839-2013%22&limit=1).

Why it’s dangerous

The recall is due to a surface defect described as discoloration or an out-of-specification result for description testing related to ink. The record does not specify if this defect causes harm, reduces effectiveness, or indicates contamination.

Who’s affected

Patients in Georgia who were prescribed Ethambutol Hydrochloride Tablets, USP 400 mg by VersaPharm. It is unclear if the discoloration poses a health risk or affects the drug's efficacy based on the provided record.

How to tell if you have this one

Look for Ethambutol Hydrochloride Tablets, USP 400 mg, 60 tablets, Rx Only, manufactured by West-Ward Pharmaceuticals Corp. for VersaPharm. The specific lot number is 69968B and the NDC is 61748-014-06.

  • Brand
    VersaPharm
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check your medication

    Verify if you have Ethambutol Hydrochloride Tablets, USP 400 mg with lot number 69968B distributed in Georgia.

  2. Consult a pharmacist

    Contact your healthcare provider or pharmacist to determine if the specific tablets you have are affected and what steps to take next.

Where it went and when

Where it was distributed

Distributed in Georgia.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: yesGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “GA” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Georgia.

Recall timeline

FDA terminated this recall 12 months after the firm started it.

1. Firm started the recall: Jun 4, 201312. FDA classified it Class II: Aug 2, 201323. Published in FDA’s Enforcement Report: Aug 14, 201334. FDA terminated the recall: Jun 5, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What is the NDC number for the affected product?

The National Drug Code (NDC) is 61748-014-06.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-839-2013 (June 4, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-839-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA